The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3

Nature

Volumn 394, Issue 6688, 1998, Pages 92-96

  Kurokawa, Mineo ^a   Mitani, Kinuko ^a   Irie, Kenji ^b   Matsuyama, Tomohiro ^a   Takahashi, Tokiharu ^a   Chiba, Shigeru ^a   Yazaki, Yoshio ^a   Matsumoto, Kunihiro ^b   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CELL STRAIN HEPG2; CELL TRANSFORMATION; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REPRESSOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIVISION; CELL LINE; COS CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; MINK; PROTO-ONCOGENES; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0032474868     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/27945     Document Type: Article

References (29)

1. Lopingco, M. C. & Perkins, A. S. Molecular analysis of Evil, a zinc finger oncogene involved in myeloid leukemia. Cur. Tap. Microbiol. Immunol. 211, 211-222 (1996).
2. Morishita, K. et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc. Natl. Acad. Sci. USA 89, 3937-3941 (1992).
3. Mitani, K. et al. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13, 504-510 (1994).
4. Ogawa, S. et al. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene 13, 183-191 (1996).
5. Ogawa, S. et al. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia 10, 788-794 (1996).
6. Morishita, K. et al. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54, 831-840 (1988).
7. Tanaka, T. et al. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain. J. Biol. Chem. 269, 24020-24026 (1994).
8. Bartholomew, C., Kilbey, A., Clark, A. M. & Walker, M. The Evi-1 proto-oncogene encodes a transcriptional represser activity associated with transformation. Oncogene 14, 569-577 (1997).
9. Kurokawa, M. et al. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Raf1 fibroblasts with dependence on the Evi-1 sequence. Oncogene 11, 833-840 (1995).
10. Morishita, K., Parganas, E., Matsugi, T. & Ihle, J. N. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol. Cell. Biol. 12, 183-189 (1992).
11. Kreider, B. L., Orkin, S. H. & Ihle, J. N. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proc. Natl Acad. Sci. USA 90, 6454-6458 (1993).
12. Massagué, J. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641 (1990).
13. Zhang, Y., Feng, X., We, R. & Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383, 168-172 (1996).
14. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. & Massagué, J. Mechanism of activation of theTGF-β receptor. Nature 370, 341-347 (1994).
15. Macias-Silva, M. et al. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224 (1996).
16. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261 (1994).
17. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M. & Massagué, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphoryiation. Cell 62, 175-185 (1990).
18. Derynck, R. & Zhang, Y. Intracellular signalling: the mad way to do it. Curr. Biol. 6, 1226-1229 (1996).
19. Massagué, J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85, 947-950 (1996).
20. Wrana, J. L. & Attisano, L. MAD-related proteins in TGFβ signaling. Trends Genet. 12, 493-496 (1996).
21. Wu, R.-Y., Zbang, Y., Feng, X.-H. & Derynck, R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol. Cell. Biol. 17, 2521-2528 (1997).
22. Nakao, A. et al. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362 (1997).
23. Wieser, R., Wrana, J. L. & Massagué, J. GS domain mutations that constitutively activate T β R-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208 (1995).
24. Yingling, J. M. et al. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol. 17, 7019-7028 (1997).
25. Tanaka, T. et al. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol. Cell. Biol. 15, 2383-2392 (1995).
26. Lagna, G., Hata, A., Hemmati, B. A. & Massagué, J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383, 832-835 (1996).
27. Hata, A., S., L. R., Wotton, D., Lagna, G. & Massagué, J. Mutations increasing autoinhibition inactive tumor suppressors Smad2 and Smad4. Nature 388, 82-87 (1997).
28. Takebe, Y. et al. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8, 466-472 (1988).
29. Kurokawa, M. et al. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts. J. Biol. Chem. 271, 16870-16876 (1996).